: Canadian Drug Price Board Member Resigns Over Government Failure Вђto Support Real Changeвђ™ - Mr Validity - Stat
In February 2023, , a member of Canada’s Patented Medicine Prices Review Board (PMPRB) , resigned in a blistering letter to the federal government. Herder , a health law expert at Dalhousie University , accused the Liberal government of failing to support "real change" and undermining the regulator's independence to favor the pharmaceutical industry. Key Reasons for Resignation
: Herder stated the government’s actions were "largely indistinguishable in form and substance from industry talking points," leaving the regulator in an "endless tunnel with no light". Context and Fallout In February 2023, , a member of Canada’s
Herder’s departure was prompted by what he described as the government’s "unwillingness to support real change" in drug pricing reform. His specific grievances included: Context and Fallout Herder’s departure was prompted by
: He criticized then-Health Minister Jean-Yves Duclos for intervening on behalf of the pharmaceutical industry by asking the board to suspend consultations on new pricing guidelines. In February 2023